The application of anti-TOP2A antibody-conjugated liposomes in the treatment of glioma is currently under investigation, representing a promising strategy in cancer therapy. These specialized liposomes are designed to bind specifically to tumor cells, allowing for more precise delivery of therapeutic agents directly to the cancer site. Consequently, this targeted approach not only minimizes the side effects typically associated with conventional treatments but also significantly enhances the overall therapeutic efficacy of the drugs administered.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1962z | Mouse Anti-TOP2A Recombinant Antibody (clone 40D5) | WB, FC, IF, IHC | Mouse IgG2b, κ |
MRO-2235-CN | Rabbit Anti-TOP2A Polyclonal Antibody (MRO-2235-CN) | WB, IF, FC | Rabbit IgG |
MRO-2237-CN | Rabbit Anti-TOP2A Polyclonal Antibody (MRO-2237-CN) | WB, IF, IHC, FC | Rabbit IgG |
VS3-FY1471 | Recombinant Mouse Anti-TOP2A Antibody (clone 1D2-2H6-7D1) | IHC-P | Mouse IgG2b |
VS3-FY2905 | Mouse Anti-TOP2A Recombinant Antibody (VS3-FY2905) | WB, ICC, FC, ELISA | Mouse IgG |
There are currently no Customer reviews or questions for VS-1024-FY136. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.